Biomarker-supported detection of paroxysmal atrial fibrillation in patients with cerebral ischemia.

Not Applicable

Completed

• Conditions: Cerebral ischemia, Atrial fibrillation; Circulatory System; Atrial fibrillation and flutter

• Registration Number: ISRCTN46104198
• Lead Sponsor: niversity Hospital Goettingen (Germany) - Department of Cardiology and Pneumology

Brief Summary

1. 2010 results in: http://www.ncbi.nlm.nih.gov/pubmed/20966415 2. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23840747 3. 2013 cost-effectiveness results in: http://www.ncbi.nlm.nih.gov/pubmed/23904073 4. 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31537188 (added 23/09/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-02-17
• Study Completion: 2011-02-28
• Last Update Posted: 29 October 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 211

Inclusion Criteria

1. Cerebral ischemia, i.e. transient ischemic attack (TIA) or stroke
2. Ability and willingness to consent
3. Age > 18 years

Exclusion Criteria

1. Inability or unwillingness to consent
2. Age < 18 years
3. Cerebral haemorrhage

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnosis of atrial fibrillation from baseline up to 12 months follow-up

Secondary Outcome Measures

Name	Time	Method
Major adverse cerebral or cardiovascular events (MACCE)